Insider Transactions Reported by 22 Insiders of BALCHEM CORP

Symbol
BCPC on Nasdaq
Location
Montvale, NJ

Insiders trading volume in the past year

BALCHEM CORP executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Theodore L. Harris Chairman, President & CEO, Director $13,218,418 12 Feb 2025
Perry W. Premdas Director $6,711,291 08 Feb 2023
Carl Martin Bengtsson EVP & Chief Financial Officer $3,936,731 12 Feb 2025
JOHN Y. TELEVANTOS Director $3,825,888 13 Feb 2023
James C. Hyde Sr. Vice President $2,093,989 15 Feb 2022
Jonathan Harrison Griffin SVP & GM, Animal Nutrition $1,851,068 11 Feb 2024
Michael Brent Tignor SVP & Chief HR Officer $1,701,550 12 Feb 2025
Job Leonard van Gunsteren SVP and GM, Specialty Products $1,452,831 -$919,723 -38.8% 04 Dec 2025
Martin Luther Reid SVP Chief Supply Chain Officer $1,232,988 -$185,328 -13.1% 11 Nov 2025
David B. Fischer Director $1,231,466 -$1,231,748 -50% 03 Dec 2025
Matthew David Wineinger Director $1,165,146 12 Feb 2025
William A. Backus VP & Chief Accounting Officer $1,043,117 12 Feb 2025
Mark A. Stach General Counsel $1,021,404 15 Feb 2022
Daniel E. Knutson Director $983,571 12 Feb 2025
Hatsuki Miyata EVP, CLO, & Secretary $979,776 25 Jul 2025
Frederic Boned SVP/GM, Human Nutri. & Health $916,786 31 Oct 2025
Michael Robert Sestrick SVP & Chief Technology Officer $915,216 12 Feb 2025
Kathleen B. Fish Director $417,475 12 Feb 2025
Joyce J. Lee Director $398,162 08 Feb 2024
Olivier Rigaud Director $247,973 12 Feb 2025
MONICA VICENTE Director $247,973 12 Feb 2025
George Graham SVP and Chief R&D Officer 20 Oct 2025

Recent Insider Transactions by Companies or Individuals for BALCHEM CORP

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.